Frontiers in Medicinal Chemistry

Volume 2

eBook: US $44 Special Offer (PDF + Printed Copy): US $309
Printed Copy: US $287
Library License: US $176
ISSN: 1567-2042 (Print)
ISSN: 1875-5763 (Online)
ISBN: 978-1-60805-673-6 (Print)
ISBN: 978-1-60805-205-9 (Online)
Year of Publication: 2005
DOI: 10.2174/97816080520591050201


Frontiers in Medicinal Chemistry is a book series devoted to the review of areas of important topical interest to medicinal chemists and others in allied disciplines. Frontiers in Medicinal Chemistry covers all the areas of medicinal chemistry, including developments in rational drug design, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, chemoinformatics, and structure-activity relationships.

Medicinal chemistry as a discipline is rapidly maturing. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Frontiers in Medicinal Chemistry aims to contribute in a major way to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. This book series is essential for any medicinal chemist who wishes to be kept informed and up-to-date with the latest and the most important advances.

Indexed in: Scopus, EMBASE, Scilit, Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.


- Pp. iv- (1)
Allen B. Reitz, Atta-ur-Rahman, Cheryl P. Kordik, M. Iqbal Choudhary
Download Free


- Pp. viii-xiii (6)
Allen B. Reitz, Atta-ur-Rahman, Cheryl P. Kordik, M. Iqbal Choudhary
Download Free

Novel Inhibitors of HIV Integrase: The Discovery of Potential Anti-HIV Therapeutic Agents

- Pp. 3-20 (18)
Vasu Nair
View Abstract

Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance

- Pp. 21-35 (15)
Marne Gaynor, Alexander S. Mankin
View Abstract

Potential New Targets for Antithrombotic Therapy

- Pp. 37-48 (12)
Andras Gruber, Stephen R. Hanson
View Abstract

Potent and Selective A2A Adenosine Receptor Antagonists: Recent Improvement

- Pp. 49-62 (14)
Barbara Cacciari, Giorgia Pastorin, Stefano Moro, Giampiero Spalluto
View Abstract

Updating the Dual Role of Brain Nitric Oxide in Neurodegeneration/Neuroprotection: Understanding Molecular Mechanisms to Devise Drug Approaches

- Pp. 63-109 (47)
Antonio Contestabile, Barbara Monti, Andrea Contestabile, Elisabetta Ciani
View Abstract

Effect of Genetic Background on Ionotropic Glutamate Receptor and Neurotrophin Biology: Synaptic Connectivity and Function in Neurological Disease

- Pp. 111-132 (22)
Gregory N. Barnes, John T. Slevin
View Abstract

Medical Marijuana in CNS Disorders

- Pp. 133-159 (27)
Alison J. Drysdale, Bettina Platt
View Abstract

Obesity and Diabetes Gene Discovery Approaches

- Pp. 161-182 (22)
Ken Walder, David Segal, Jeremy Jowett, John Blangero, Greg R. Collier
View Abstract

Understanding the Molecular Mechanism of Action of Estrogen Receptor Modulators

- Pp. 183-231 (49)
Mary J. Meegan, David G. Lloyd
View Abstract

Recent Advances in Peroxisome Proliferator- Activated Receptor Science

- Pp. 233-251 (19)
Barry G. Shearer, William J. Hoekstra
View Abstract

Recent Developments in the Synthesis and Evaluation of Glucose Analog Inhibitors of Glycogen Phosphorylases as Potential Antidiabetic Agents

- Pp. 253-272 (20)
Laszlo Somsak, Veronika Nagy, Zsuzsa Hadady, Nora Felfoldi, Tibor Docsa, Pal Gergely
View Abstract

Regulation by Nicotine of Food Intake and Body Weight: Implications for Obesity Treatment

- Pp. 273-297 (25)
Ming D. Li, Justin K. Kane, Ozlen Konu
View Abstract

Histone Deacetylase Inhibitors: From Chromatin Remodelling to Experimental Cancer Therapeutics

- Pp. 299-315 (17)
Janine Arts, Stefanie de Schepper, Kristof Van Emelen
View Abstract

Radiogenetic Therapy Using Radiation-Responsive Gene Promoters

- Pp. 317-330 (14)
Brian Marples, Olga Greco, Michael C. Joiner, Simon D. Scott
View Abstract

Inhibitors of Farnesyltransferase and Geranylgeranyltransferase-I for Antitumor Therapy: Substrate-Based Design, Conformational Constraint and Biological Activity

- Pp. 331-355 (25)
Christopher J. Dinsmore, Ian M. Bell
View Abstract

Enediyne Natural Products: Biosynthesis and Prospect Towards Engineering Novel Antitumor Agents

- Pp. 357-369 (13)
Ben Shen, Wen Liu, Koichi Nonaka
View Abstract

Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors

- Pp. 371-391 (21)
Marco Presta, Daria Leali, Helena Stabile, Roberto Ronca, Maura Camozzi, Emanuela Moroni, Stefania Nicoli, Sandra Liekens, Marco
View Abstract

VIP and Drug Design 2004

- Pp. 393-415 (23)
Illana Gozes, Sharon Furman
View Abstract

Chemical Genomics-Based Target Mining and Validation of Biologically Active Small Molecules

- Pp. 417-430 (14)
Ho Jeong Kwon
View Abstract

Ethnobotany and Natural Products: The Search for New Molecules, New Treatments of Old Diseases or a Better Understanding of Indigenous Cultures?

- Pp. 431-450 (20)
Michael Heinrich
View Abstract

Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases

- Pp. 451-484 (34)
Michael T. Wilson, Luc Van Kaer
View Abstract

Combinatorial Synthesis of Small Molecule Libraries by Microwave Technology

- Pp. 485-510 (26)
Chung-Ming Sun
View Abstract

Pharmacophore Discovery - Lessons Learned

- Pp. 511-532 (22)
John H. van Drie
View Abstract

Drug Discovery Today

- Pp. 533-543 (11)
Oliver Schwardt, Brian Cutting, Hartmuth Kolb, Beat Ernst
View Abstract

Theoretical Property Predictions

- Pp. 545-570 (26)
David J. Livingston
View Abstract

Prediction of Drug Metabolism: The Case of Cytochrome P450 2D6

- Pp. 571-586 (16)
Nico P.E. Vermeulen
View Abstract

Subject Index to Volume 2

- Pp. 587-606 (20)
Bentham Science Publishers
Download Free